| Golden Valley Health Center | |
|
198 N. G Street Empire CA 95319 | |
| (209) 522-1010 | |
| (209) 522-1014 |
| Full Name | Golden Valley Health Center |
|---|---|
| Speciality | Clinic/Center |
| Location | 198 N. G Street, Empire, California |
| Authorized Official Name and Position | Tony Weber (CEO) |
| Authorized Official Contact | 2093855551 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Golden Valley Health Center 1910 Customer Care Way Atwater CA 95301-5167 Ph: (209) 384-6493 | Golden Valley Health Center 198 N. G Street Empire CA 95319 Ph: (209) 522-1010 |
| NPI Number | 1326493115 |
|---|---|
| Provider Enumeration Date | 04/28/2016 |
| Last Update Date | 07/21/2022 |
| Medicare PECOS PAC ID | 4183527187 |
|---|---|
| Medicare Enrollment ID | O20170725002222 |
News Archive
Spectral Diagnostics Inc., today announced that it has signed a long-term, exclusive distribution agreement with Toray Industries, Inc. and Toray Medical Co., Ltd. of Japan (collectively "Toray") to market and sell Toraymyxin™ in Canada. Toraymyxin™ is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream. This product and Spectral's EAA™ diagnostic, which measures endotoxin and identifies patients for treatment, are already approved for sale by Health Canada.
Medical Present Value, Inc. (MPV) today announced new contracts with four physician groups representing more than 2,600 providers to help monitor payer compliance and automate processes related to payer adjudication management and oversight.
The Global Antibiotic Research & Development Partnership and Novartis are joining forces to accelerate the development and availability of generic antibiotic treatments for children in low- and middle-income countries.
The Protein Society, an international, trans-disciplinary community of scientists dedicated to protein research, announces the third annual selection of two Protein Science authors as winners of the 2015 Best Paper Awards.
Researchers at the University of Maryland School of Medicine in Baltimore report that a new, highly sensitive investigative blood test may help predict the risk of heart failure and cardiovascular death much earlier than previously possible in older people who do not have symptoms of heart failure.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326493115 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QF0400X | Clinic/center - Federally Qualified Health Center (fqhc) | (* (Not Available)) | Primary |
News Archive
Spectral Diagnostics Inc., today announced that it has signed a long-term, exclusive distribution agreement with Toray Industries, Inc. and Toray Medical Co., Ltd. of Japan (collectively "Toray") to market and sell Toraymyxin™ in Canada. Toraymyxin™ is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream. This product and Spectral's EAA™ diagnostic, which measures endotoxin and identifies patients for treatment, are already approved for sale by Health Canada.
Medical Present Value, Inc. (MPV) today announced new contracts with four physician groups representing more than 2,600 providers to help monitor payer compliance and automate processes related to payer adjudication management and oversight.
The Global Antibiotic Research & Development Partnership and Novartis are joining forces to accelerate the development and availability of generic antibiotic treatments for children in low- and middle-income countries.
The Protein Society, an international, trans-disciplinary community of scientists dedicated to protein research, announces the third annual selection of two Protein Science authors as winners of the 2015 Best Paper Awards.
Researchers at the University of Maryland School of Medicine in Baltimore report that a new, highly sensitive investigative blood test may help predict the risk of heart failure and cardiovascular death much earlier than previously possible in older people who do not have symptoms of heart failure.
› Verified 1 days ago